Le Lézard
Classified in: Health, Covid-19 virus
Subject: PSF

Florida's Life Sciences Industry Launches Vaccine Education Campaign


WEST PALM BEACH, Fla., March 25, 2021 /PRNewswire/ -- While there is much excitement about the arrival of the COVID-19 vaccine, there is also some skepticism with polls showing that up to 30 percent of Americans say they are not sure that they will get the vaccine. To ensure confidence in the COVID-19 vaccine, BioFlorida has launched the COVID-19 Vaccine Facts educational resource to link Floridians to third-party scientific and evidenced-based information related to the vaccine development and distribution process. Topics include safety, efficacy, availability, and affordability of COVID-19 vaccines.

The resource, which is translated in English and Spanish, provides Floridians with answer to "frequently asked questions" related to vaccine development and distribution, including:

"Organizations from all over the world including our Florida-based companies, research organizations, universities, health systems, and labs have made significant advancements to discover the vaccines, therapeutics, and other tools to address COVID-19," said Nancy K. Bryan, President & CEO of BioFlorida. "We all have unique roles in the COVID-19 fight, and we hope BioFlorida's COVID-19 Vaccine Facts online resource will serve as a comprehensive resource for our companies, community partners, and government officials to educate the public on the scientifically rigorous, transparent, and safety-focused vaccine development process to build trust in our industry's unprecedented response to this pandemic."

The resource will continue to be updated in partnership with the Biotechnology Innovation Organization (BIO). The resources have been independently reviewed by health experts and incorporate several visual elements to help explain concepts like herd immunity, emergency use authorization, and more.

BioFlorida has also aggregated vaccine resources on distribution, corporate guidance, and news from Florida companies making a difference in the fight against COVID-19.

The BioFlorida COVID-19 Vaccine Facts educational resource can be found by visiting: https://www.bioflorida.com/page/covid19vaccine.

About BioFlorida  
BioFlorida is the voice of Florida's life science industry, representing 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors in BioPharma, MedTech, HealthIT and BioAg that collectively employ 94,000 Floridians. [Source: The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life (TEConomy/BIO, 2020)] BioFlorida's member driven initiatives provide a strong business climate for the advancement of innovative products and technology that improve lives and promote economic benefits to the state.

SOURCE BioFlorida


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: